Key result
Childhood spinal muscular atrophy is linked to subclinical ventricular dysfunction and abnormal diastolic filling.
Why the study?
Little is known regarding the cardiac function of children with spinal muscular atrophy.
Does spinal muscular atrophy affect cardiac function and biomarkers in children compared to healthy controls?
Case-Control (n=76)
No
Does spinal muscular atrophy affect cardiac function and biomarkers in children compared to healthy controls?
Children with spinal muscular atrophy demonstrate subclinical ventricular dysfunction and elevated cardiac biomarkers, highlighting the need for routine cardiac monitoring in this population.
Answers are grounded in this paper and cite their sources.
Subclinical ventricular dysfunction in pediatric SMA may support monitoring; case-control data leaves open prospective validation.
BACKGROUND: Spinal muscular atrophy (SMA) is an autosomal recessive disorder characterized by degeneration of lower motor neurons, resulting in progressive muscle weakness and atrophy. However, little is known regarding the cardiac function of children with SMA. METHODS: We recruited SMA patients younger than 18 years of age from January 1, 2022, to April 1, 2022, in the First Affiliated Hospital of Sun Yat-sen University. All patients underwent a comprehensive cardiac evaluation before treatment, including history taking, physical examination, blood tests of cardiac biomarkers, assessment of echocardiography and electrocardiogram. Age/gender-matched healthy volunteers were recruited as controls. RESULTS: A total of 36 SMA patients (26 with SMA type 2 and 10 with SMA type 3) and 40 controls were enrolled in the study. No patient was clinically diagnosed with heart failure. Blood tests showed elevated values of creatine kinase isoenzyme M and isoenzyme B (CK-MB) mass and high-sensitivity cardiac troponin T (hs-cTnT) in spinal muscular atrophy (SMA) patients. Regarding echocardiographic parameters, SMA children were detected with lower global left and right ventricular longitudinal strain, abnormal diastolic filling velocities of trans-mitral and trans-tricuspid flow. The results revealed no clinical heart dysfunction in SMA patients, but subclinical ventricular dysfunction was seen in SMA children including the diastolic function and myocardial performance. Some patients presented with elevated heart rate and abnormal echogenicity of aortic valve or wall. Among these SMA patients, seven patients (19.4%) had scoliosis. The Cobb's angles showed a significant negative correlation with LVEDd/BSA, but no correlation with other parameters, suggesting that mild scoliosis did not lead to significant cardiac dysfunction. CONCLUSIONS: Our findings warrant increased attention to the cardiac status and highlight the need to investigate cardiac interventions in SMA children.
No takes yet. Share an insight, caveat, or question.
He et al. (2024) conducted a case-control in Spinal muscular atrophy (n=76). Spinal muscular atrophy vs. Healthy volunteers was evaluated on Cardiac function and biomarkers. Children with spinal muscular atrophy exhibited subclinical ventricular dysfunction, including lower global ventricular longitudinal strain and abnormal diastolic filling, compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: